Your email has been successfully added to our mailing list.

×
0 0 0 0 0 0 0 0
Stock impact report

Endologix expects Nellix premarket approval in early 2021 [Seeking Alpha]

ENDOLOGIX (ELGX) 
Last endologix earnings: 2/19 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investor.endologix.com
Company Research Source: Seeking Alpha
Endologix (NASDAQ: ELGX ) has updated expectations on approval of its Nellix 3.5 product. In an SEC filing after today's close, the company says it anticipates the FDA will OK its premarket approval application for the endovascular aneurysm sealing system in the first half of 2021. That's based on current enrollment rates in the Company’s EVAS2 clinical confirmatory study and other factors. Shares today after yesterday's earnings report . Earnings call slides See all stocks on the move » Now read: Endologix Inc 2018 Q2 - Results - Earnings Call Slides » Subscribe for full text news in your inbox Show less Read more
Impact Snapshot
Event Time:
ELGX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for ELGX alerts
Opt-in for
ELGX alerts

from News Quantified
Opt-in for
ELGX alerts

from News Quantified